ArticlePloS one2026
Macroscopic aspergillus recognition using YOLO-CSM.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aspergillus detection is of great significance in medical diagnosis and microbiological analysis. However, due to the complex morphology of Aspergillus, its subtle structural characteristics, the presence of rare strains, and partial occlusion in samples, traditional detection methods often fail to achieve high accuracy. To address these challenges, this study incorporates three innovative modules-CGNet, Shape-IoU, and MSCA-into the YOLOv12 framework to construct an efficient Aspergillus detection model. CGNet enhances the fusion and representation of complex structural features; Shape-IoU introduces morphological constraints to improve matching accuracy in scenarios with occlusion and blurred boundaries; and MSCA strengthens the model's adaptability to strains of different scales. Experimental results show that the proposed model achieves a Precision of 92.1%, Recall of 87.8%, and mAP of 89.2% in Aspergillus detection, while requiring only 28.6M parameters, effectively balancing accuracy and lightweight design. These results demonstrate the superiority of the proposed method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.